Category: Zacks Small Cap Research
OTC:GBTC Investors interested in the cryptocurrency market or invested in the publicly traded Grayscale Bitcoin Trust (OTC:GBTC), which provides investment exposure to Bitcoin, have few ways to obtain information and analysis. Generally, they need to ...
By John Vandermosten, CFANYSE:CVM READ THE FULL CVM RESEARCH REPORT The Last Review? CEL-SCI Corporation (NYSE:CVM) today announced its second Independent Data Monitoring Committee (IDMC) review this year for the IT MATTERS Phase III Multikine study ...
By Brian Marckx, CFAOTC:PBSVREAD THE FULL PBSV RESEARCH REPORTRevenue, Profitability at 6-Year Highs. Big Cash, Stellar Balance Sheet Enhances Growth Prospects……Not only has Pharma-Bio Serv’s (OTC:PBSV) revenue rebounded from the disruptions caused b ...
By Ian Gilson, PhD, CFANASDAQ:EASTREAD THE FULL EAST RESEARCH REPORTSteve Shum, the company's interim CEO and current CFO has resigned from Eastside Distilling (NASDAQ:EAST) to become the CEO of another company. The board of directors is looking for ...
By David Bautz, PhDNASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update New Preclinical Data for EPI-7386 Presented at ESMO On September 28, 2019, ESSA Pharma Inc. (NASDAQ:EPIX) announced new preclinical data was presented at the European S ...
By Lisa ThompsonOTC:NEXCF READ THE FULL NEXCF RESEARCH REPORT NexTech AR (OTC:NEXCF) is a small, B2B startup based in Toronto that was formed to provide services for, and invest in, businesses using Augmented Reality (AR) and hologram technologies. T ...
By Lisa ThompsonNASDAQ:MOGO READ THE FULL MOGO RESEARCH REPORT Today Mogo (NASDAQ:MOGO) announced a long awaited partnership with a lending institution to accelerate its loan growth and move future loans off its balance sheet to reduce debt. It annou ...
By John Vandermosten, CFANASDAQ:VVUS Vivus, Inc. (NASDAQ:VVUS) announced the pay down of $48.6 million of its senior secured notes due 2024. The securities were yielding 10.375% and their early retirement is expected to save Vivus $10.5 million over ...
By David Bautz, PhDNASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update Phase 3 Clinical Trial to Initiate in 4Q19 On October 2, 2019, ContraFect Corp. (NASDAQ:CFRX) announced that following a successful ‘end-of-Phase 2’ meeting with the FD ...
NASDAQ:SNES BackgroundSenesTech Inc., head-quartered in Flagstaff, AZ was founded in 2004. The firm has developed a solution for managing pests through fertility control. Their current marketed product, ContraPest®, a liquid bait, limits fertility ...